Cincinnati Wellness Review: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Cincinnati Wellness Review.

December 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

January 2026

Mo	Tu	We	Th	Fr	Sa	Su
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

February 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

Press releases published on December 23, 2025

Dec. 23, 2025

Pelthos Therapeutics Expands Board of Directors with the Appointment of Andrew Einhorn

GlobeNewswire

Dec. 23, 2025

Can-Fite Announces Reverse Split of its Ordinary Shares and ADS Ratio Change

GlobeNewswire

Dec. 23, 2025

Vor Bio Appoints RA Capital’s Andrew Levin, M.D., Ph.D., and Forbion’s Wouter Joustra to Board of Directors

GlobeNewswire

Dec. 23, 2025

Algernon Announces Increase to Private Placement Financing to $750,000 and Close of Third Tranche

GlobeNewswire

Dec. 23, 2025

On the Anniversary of the World's First Successful Kidney Transplant, Renown Transplant Institute Celebrates Second and Third Successful Transplants

GlobeNewswire

Dec. 23, 2025

Singlera Genomics Signs European Distribution and Research Agreement with Pure Medical for Cancer Detection Products

GlobeNewswire

Dec. 23, 2025

Sequana Medical announces execution of letter of intent to amend terms of the Kreos Loan

GlobeNewswire

Dec. 23, 2025

Qualifacts and Richstone Center Partner to Modernize Trauma-Informed Care Across Los Angeles County

GlobeNewswire

Dec. 23, 2025

ABC Calls on Congress to Act Now to Modernize Blood Center Regulations

GlobeNewswire

Dec. 23, 2025

Prenetics Enters Into Warrant Exchange Agreements With Warrant Holders, Strengthening Capital Structure

GlobeNewswire

Dec. 23, 2025

Press Release: Sanofi’s Wayrilz approved in the EU as the first BTK inhibitor to treat immune thrombocytopenia

GlobeNewswire

Dec. 23, 2025

Communiqué de presse : Wayrilz de Sanofi approuvé dans l’UE comme premier inhibiteur de la BTK pour le traitement de la thrombocytopénie immunitaire (TPI)

GlobeNewswire

Dec. 23, 2025

Merit Medical to Participate at the J.P. Morgan Healthcare Conference

GlobeNewswire

Dec. 23, 2025

Kailera Therapeutics to Present at 44th Annual J.P. Morgan Healthcare Conference

GlobeNewswire

Dec. 23, 2025

J-Star’s LITZMO Introduces ER-01: The Brand’s First Carbon Fiber Fat-Tire E‑Assist Bicycle

GlobeNewswire

Dec. 23, 2025

MAPS Supports Therapy Education for First-Ever Department of Defense-Affiliated MDMA-Assisted Therapy Pilot

GlobeNewswire

Dec. 23, 2025

Artelo Bioscience Commends Presidential Executive Order Expanding CBD Research and Access; Highlights ART12.11 as a Leading Pharmaceutical-Grade Cannabidiol Candidate

GlobeNewswire

Dec. 23, 2025

Windtree Therapeutics Announces the Sale of its Cardiovascular Biotech Pipeline Drug Candidates

GlobeNewswire

Dec. 23, 2025

HealthLynked Announces Strategic Consulting Partnership With PBACO to Accelerate Payer Integration and Value-Based Care

GlobeNewswire

Dec. 23, 2025

Trinity Biotech Announces Agreements to Strengthen Capital Structure and Support Growth Initiatives

GlobeNewswire